Dipeptidyl peptidase 4 (DPP-4) inhibitors are widely used as therapeutic agents for diabetes mellitus, reducing serum glucose levels by inhibiting glucagon--like peptide--1(GLP-1) and gastric inhibitory polypeptide (GIP) degradation (14,15). The gene discussed is GIP; the disease is diabetes mellitus.